Who Should Not Be Included in Research Protocols Using These Compounds Research exclusion criteria documented in clinical trials for both compounds include subjects with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and severe gastrointestinal disease [5][8]
Its pharmacological activity, primarily attributed to cinnamaldehyde (CHO), a phenylpropanoid compound, imparts cinnamons characteristic aroma and exerts anti-inflammatory, antioxidant, and insulin-sensitizing effects (52)
doi: 10.1016/s0950-351x(98)80008-6
I would hate to scare somebody out of bettering their health just because I've got some bat wings on," she laughed
The Significant Role of Carnitine and Fatty Acids during Pregnancy, Lactation and Perinatal Period